INVESTIGADORES
COCCA Claudia Marcela
artículos
Título:
An experimental model of diabetes and cancer in rats.
Autor/es:
COCCA C; MARTÍN G; E RIVERA; DAVIO C; CRICCO G; LEMOS B; FITZSIMONS C; GUTIÉRREZ A; LEVIN E; LEVIN R; CROCCI M; BERGOC R
Revista:
EUROPEAN JOURNAL OF CANCER
Editorial:
ELSEVIER SCI LTD
Referencias:
Lugar: Amsterdam; Año: 1998 vol. 34 p. 889 - 894
ISSN:
0959-8049
Resumen:
The aim of this study was to develop an experimental model for the study of cancer associated with diabetes. For diabetes induction, Sprague-Dawley rats were given streptozotocin (STZ, 90 mg/kg body weight (BW), by intraperitoneal injection on the second day of life. For mammary tumour induction, rats were injected with 50 mg/kg BW of N-nitroso-N-methylurea (NMU) at 50, 80 and 110 days old. The neoplastic process and the effect of tamoxifen treatment was examined in non-diabetic and diabetic rats. The latency period, NMU-induced tumour incidence and the number of tumours per rat in diabetic rats versus controls were 117 +/- 7 days versus 79 +/- 9 days (P < 0.001); 93% versus 95% (NS); and 5.2 +/- 1.6 versus 2.7 +/- 0.5 (P < 0.02). A more benign histological pattern for tumours in diabetic animals was observed. Mammary tumours in diabetic rats grew more slowly than in controls. Tamoxifen (1 mg/kg/day) treated diabetic rats showed tumour regression in 67% of NMU-induced mammary tumours versus 53% in controls (NS). Our results show that tumour progression seems to be affected by diabetes in this experimental model. We suggest this is the result of changes to insulin-like growth factors and their receptors, which occur in diabetics, and our future research will examine this hypothesis.